PFM Health Sciences’s Expedia Group EXPE Stock Holding History

PFM Health Sciences’s Portfolio EXPE Stock Details EXPE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-484,412	Closed	-$35.1M	–	70
2014 Q1	$35.1M	Buy	+484,412	New	+$35.1M	0.64%	45

Other funds holding EXPE

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

PCM

PAR Capital Management Boston, Massachusetts $4.03B AUM 35.05% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

PFM Health Sciences's EXPE Position: Q2 2014 in Review

PFM Health Sciences sold out of Expedia Group (EXPE) in Q2 2014, closing a stake of 484,412 shares — an estimated $35.1M sold.

PFM Health Sciences first reported a position in EXPE in Q1 2014 and held it in 1 quarter. The position peaked at $35.1M in Q1 2014. 376 funds tracked by Wall St. Rank hold EXPE as of Q2 2014.

PFM Health Sciences reported no remaining Expedia Group position as of Q2 2014 after selling out during the quarter.
PFM Health Sciences sold 484,412 Expedia Group shares in Q2 2014, an estimated $35.1M.
PFM Health Sciences first reported a position in Expedia Group in Q1 2014 and held it in 1 quarter.
PFM Health Sciences's Expedia Group position peaked at $35.1M in Q1 2014.
376 funds tracked by Wall St. Rank held Expedia Group as of Q2 2014.

Based on PFM Health Sciences's 13F filing for Q2 2014, filed 14 Aug 2014.